Cargando…
Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease
Autores principales: | Kim, Eun Na, Do, Hyo‐Sang, Jeong, Hwangkyo, Kim, Taeho, Heo, Sun Hee, Kim, Yoo‐Mi, Cheon, Chong Kun, Lee, Yena, Choi, Yunha, Choi, In Hee, Choi, Jeongmin, Yoo, Han‐Wook, Kim, Chong Jai, Zimran, Ari, Kim, Kyunggon, Lee, Beom Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121313/ https://www.ncbi.nlm.nih.gov/pubmed/35593204 http://dx.doi.org/10.1002/ctm2.862 |
Ejemplares similares
-
Phenotypic and molecular spectra of patients with switch/sucrose nonfermenting complex-related intellectual disability disorders in Korea
por: Lee, Yena, et al.
Publicado: (2021) -
The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects
por: Kim, Yoo-Mi, et al.
Publicado: (2020) -
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy
por: Kim, Yoon-Myung, et al.
Publicado: (2020) -
Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression
por: Kang, Eungu, et al.
Publicado: (2022) -
Clinical and genetic analyses of patients with lateralized overgrowth
por: Kim, Yoon-Myung, et al.
Publicado: (2022)